Which Bhringraj? Eclipta and Its Look-Alikes

"Bhringraj" is a trade name, not a species. In Indian markets it is applied to at least two different plants in two different genera, and the scientific literature carries the main one under two binomials that most searchers only ever type one of. Before any claim about bhringraj can be assessed, the question which plant? has to be answered — because a study is only evidence about the species it used.

This page sorts out the names, gives the field characters that separate the plants, explains why the obvious laboratory test cannot tell the two commercial bhringrajes apart, and then lists, study by study, which plant each of the papers cited across this Benefits leg actually worked on. That last section is the point of the page: borrowed evidence is the commonest way a herb page overstates itself, and the cure is to label every citation with its species rather than issuing one disclaimer at the top.

Table of Contents

  1. Why the Species Question Comes First
  2. Eclipta: One Plant, Three Binomials
  3. Kesharaja and the Regional Names
  4. Peela Bhringraj Is a Different Genus
  5. Why the Marker Compound Cannot Settle It
  6. Field Look-Alikes and How to Separate Them
  7. A Genus Is Not a Safety Category
  8. Which Plant Each Cited Study Used
  9. How Identity Is Actually Verified
  10. Reading a Label
  11. What We Do Not Know
  12. Key Research Papers
  13. Connections

Why the Species Question Comes First

A herb claim is a claim about a species, a plant part, a preparation and a route. Change any one of those and it is a different intervention, however similar the label sounds. Bhringraj changes the first one in ordinary commerce, which puts it in a small category of herbs where the buyer genuinely may not know what is in the bottle.

Three separate confusions stack up:

  1. A nomenclatural split within one species. The plant appears in the literature as both Eclipta alba and Eclipta prostrata, and searching one name misses roughly half the papers.
  2. A genuine two-genus trade name. Classical Ayurveda distinguishes bhringaraja by flower colour, and the white and yellow ones are not the same plant.
  3. A marker compound shared across both genera, so the chemical test a manufacturer is most likely to run does not discriminate them.

None of that makes the plant dangerous or the tradition confused — the tradition was explicit that these were different drugs. It makes the modern supply chain imprecise, and it means a reader comparing two products, or two studies, needs to check the binomial rather than the brand.

Eclipta: One Plant, Three Binomials

These are one species. Eclipta prostrata is the currently accepted botanical name and the one used in Chinese pharmacopoeial and most East Asian work. Eclipta alba is the name used in the overwhelming majority of the Indian pharmacology literature, in Ayurvedic pharmacopoeial monographs, and on product labels. Older Indian sources and some herbals use Eclipta erecta.

The practical consequence is a search problem, not a botanical one. A PubMed search for Eclipta prostrata and one for Eclipta alba return substantially different sets; the union is retrieved by searching all three names together. Any review of "the evidence for bhringraj" that used one name has silently sampled half the field, and reviews written from a single-name search are common.

The genus is small. Eclipta contains only a handful of accepted species, of which E. prostrata is by far the most widespread — a pantropical weed of wet ground. That is useful: within the genus there is very little scope for confusion, because in most places there is only one Eclipta to find. The confusion is entirely between genera.

Kesharaja and the Regional Names

The Sanskrit bhringaraja (भृङ्गराज) is usually glossed as "king of the bees" or "lord of the bees", from bhringa, a bee or large black insect. The name that matters for the hair claim is the synonym kesharaja — kesha, hair; raja, king — "king of hair", which is also the source of the Bengali kesharaj and keshuti. The Ayurvedic classification is keshya, a hair-benefiting drug.

It is worth being clear about what a name like that does and does not establish. It is evidence of intent and of long, consistent use — this plant was the tradition's designated hair drug, not a modern promotion, and it is the herb curry leaf was recently promoted past online. It is not evidence of effect. A name records what people believed a plant did; it cannot record whether they were right. Compare the opposite case, where a common name imports a safety assumption the plant does not have: "motherwort" invites the reader to assume pregnancy safety and its etymology means the reverse. Kesharaja carries no such trap — the name says "hair", nothing more, and that reading comes back clean.

Other names for the same plant: Hindi bhringraj, bhangra, babri; Tamil karisalankanni, the name under which it is central to Siddha practice; Telugu guntagalagara; Malayalam kayyonni; Kannada garagadasoppu; Chinese 墨旱蓮 mo han lian, "ink drought-lotus", drug name Ecliptae Herba; Vietnamese cỏ mực ("ink grass") and nhọ nồi ("soot from the cooking pot"); English false daisy, yerba de tago.

Notice how many of those names describe the black stain rather than hair. The plant's sap oxidises to blue-black within minutes of crushing, and that property is both its most reliable identification test and the origin of the belief that it darkens grey hair — a dye effect, examined on the hair-growth page.

Peela Bhringraj Is a Different Genus

Classical Ayurvedic texts recognise bhringaraja by flower colour, and the two commercially relevant kinds are different species in different genera:

So a packet labelled only "bhringraj" may legitimately contain either of the first two. They are both real traditional drugs with overlapping but not identical reputations, and the yellow one has its own separate research literature — a live search for Wedelia chinensis, Wedelia calendulacea and Sphagneticola calendulacea shows what is there. Findings from it are not findings about Eclipta, and vice versa.

Why the Marker Compound Cannot Settle It

This is the part that surprises people, and it is the single most useful fact on this page.

The marker constituent of bhringraj is wedelolactone, a coumestan, accompanied by demethylwedelolactone and their glucosides. A coumestan is a fused coumarin-benzofuran system sitting inside the broader isoflavonoid family. Wedelolactone is the compound a manufacturer would assay to show a product is "genuine bhringraj", and the compound most extract standardisation is nominally expressed against.

It occurs in both genera. The name is the giveaway: wedelolactone was characterised from Wedelia, not from Eclipta. Wagner and colleagues reported coumestans as the main active principles of the liver drugs Eclipta alba and Wedelia calendulacea in Planta Medica in 1986 — a single paper covering both plants precisely because they share the chemistry that the tradition's liver use was attributed to.

Three consequences follow, and all three are routinely missed:

  1. A wedelolactone assay is a potency check, not an identity check. "Standardised to wedelolactone" is compatible with either species. If identity matters to you, the assay does not deliver it.
  2. Part of the traditional overlap has a chemical explanation. Both plants were used for liver complaints and both contain the same coumestans, which is a rare case where two traditional drugs sharing an indication also share a plausible active constituent. That is a point in the tradition's favour, and it should be said as clearly as the objections are.
  3. It cuts the other way for the hair claim. The rodent hair work was done on Eclipta, not on Wedelia, and the constituent responsible was never identified. Shared wedelolactone content is therefore no basis for expecting yellow bhringraj to do the same thing.

The other constituent classes are more discriminating in principle — Eclipta's ecliptasaponins and eclalbasaponins (oleanane-type triterpene glycosides, the fraction that makes a decoction foam), its luteolin and apigenin, its sterols, and its root thiophenes such as α-terthienyl. A fingerprint across several of those is what a real authentication method uses, rather than one marker peak.

Field Look-Alikes and How to Separate Them

For anyone harvesting or inspecting raw herb, the separations are straightforward once you know what to look at.

Eclipta prostrata. Prostrate to weakly ascending annual, rarely over 30–60 cm. Leaves opposite, nearly stalkless, narrow lance-shaped, with a scattering of stiff white appressed hairs that make the surface feel rough. Flower heads small, 6–8 mm, solitary on short stalks in the leaf axils or at stem tips, with short white ray florets around a greenish-yellow disc. Wet ground: paddy bunds, ditches, pond margins. Crushed tissue blackens.

Yellow bhringraj (Wedelia / Sphagneticola calendulacea). Creeping, rooting at the nodes, forming mats. Leaves opposite but toothed or shallowly lobed and broader. Heads distinctly larger with conspicuous yellow rays — a small daisy that reads as yellow from several metres away. Also a wet-ground plant, often on the same bund.

Sphagneticola trilobata, the Singapore daisy or wedelia of landscaping. A vigorous pantropical invasive with glossy, distinctly three-lobed leaves and yellow heads, planted as groundcover and escaping everywhere. It is not a bhringraj of either colour, and its abundance in exactly the disturbed damp places where the others grow makes it the commonest mistaken "yellow bhringraj" in casual foraging.

Tridax procumbens, coat buttons. Another sprawling pantropical Asteraceae weed of the same habitats, with coarsely toothed, sometimes lobed leaves and pale creamy-yellow rays whose tips are conspicuously three-toothed, on longer stalks. Confusable at a glance with a pale-flowered composite of the same growth form.

Two decisive checks. Ray colour separates white from yellow immediately. Then crush a leaf and wait two minutes: Eclipta's sap darkens towards blue-black and stains the fingers. That stain is why the plant is called ink grass in Vietnamese and soot-of-the-pot in the same language, and it is a genuinely useful field test.

A limit worth stating plainly. Everything above concerns identifying a whole living plant. Once material is dried, milled to a powder, or infused into an oil, none of it is available to a buyer. This page is not asserting that commercial bhringraj is commonly adulterated — no survey is cited here because none is being relied on, and inventing a contamination rate would be worse than saying nothing. The honest statement is narrower and still useful: the trade name is genuinely ambiguous, and powder or oil removes your ability to check. If you cannot tell which plant you bought, that is a reason to buy on binomial and documentation, not a reason for reassurance.

A Genus Is Not a Safety Category

One reason to care about the two-genus confusion beyond pedantry: relatives are not interchangeable on safety either. The veterinary literature records hepatotoxicosis in livestock from Wedelia glauca — a South American species now usually placed in Pascalia — with the toxicity attributed to atractyloside-type compounds; a live search for Wedelia glauca hepatotoxicity shows that work, and this page does not assert its metadata beyond that description.

To be explicit about what that does and does not mean:

The same logic runs in the exculpatory direction for Eclipta, and it is worth recording because readers arrive from other Asteraceae pages expecting the family's famous hazard. Eclipta is not a pyrrolizidine-alkaloid plant. Hepatotoxic pyrrolizidine alkaloids in the daisy family are concentrated in the tribes Senecioneae (Senecio, Petasites, coltsfoot) and Eupatorieae. Eclipta sits in Heliantheae, the sunflower tribe, and pyrrolizidine alkaloids are not part of its reported constituent profile. That is a checked-and-clear finding, not an absence of interest.

Which Plant Each Cited Study Used

Per-citation labelling, so no claim on this site inherits evidence from a plant it was not tested on. This is the list to check any bhringraj article against.

Read down that list and the shape of the evidence base is visible at a glance: Eclipta-specific results are animal or in vitro; the compound-level results are about a molecule; the human-level results are about manufacturing quality. There is no row in which a human took this species and an outcome was measured.

How Identity Is Actually Verified

Naming the methods matters, because it shows the question is answerable and lets a reader ask a supplier a precise question.

  1. Macroscopic and microscopic examination of the crude drug — leaf arrangement, the appressed bristle hairs, achene morphology, stomatal type. This is what a pharmacopoeial monograph specifies, and it works on dried whole herb but not on powder.
  2. Thin-layer chromatography or HPLC fingerprinting against a reference standard, quantifying wedelolactone and ideally demethylwedelolactone and one or more saponins. Potency plus a partial fingerprint; see wedelolactone HPLC quantification in Eclipta.
  3. DNA barcoding — sequencing a standard locus such as ITS2, rbcL or matK. This is the method that answers the question the chemistry cannot, because it distinguishes genera regardless of processing, and it survives milling. See DNA barcoding for herbal raw-drug authentication.
  4. Pharmacopoeial monographs — the Ayurvedic Pharmacopoeia of India carries a monograph for bhringaraja, and the Chinese Pharmacopoeia one for Ecliptae Herba. A supplier claiming compliance with a named monograph has committed to identity tests that can be asked about.

What a buyer can realistically do is narrower: buy from a manufacturer that states the binomial, states the plant part, and will supply a certificate of analysis. That is the actionable version of everything above.

Reading a Label

Everything on this page reduces to five things to look for, in descending order of how much they tell you.

  1. A binomial, not a trade name. Eclipta prostrata or Eclipta alba means the white-flowered plant. "Bhringraj" alone does not, and "bhringraj (peela)" or "peeli bhangra" means the other genus. A manufacturer unwilling to print a binomial has told you something.
  2. The plant part. Aerial parts or whole herb is what both traditions use. "Root" alone would be unusual and is where the thiophenes concentrate. "Extract" without a part is not a specification.
  3. Powder or extract, and if extract, the ratio. A 10:1 extract and a plain milled powder are different products at the same nominal milligram dose, and this is the commonest silent difference between two capsules that look identical on the shelf.
  4. For oils: the carrier oil named, and Eclipta high in the ingredient list. Sesame or coconut is traditional. A mineral-oil base with Eclipta listed after the fragrance is a cosmetic, not a taila. A genuine medicated oil is dark green-brown and smells strongly herbal rather than perfumed.
  5. Third-party heavy-metal testing, with a batch certificate of analysis available on request rather than a generic claim on the carton. The reasoning is on the oils and safety page.

What no label will tell you is the wedelolactone content, because almost nobody assays it and no survey exists of what commercial products contain. That is a limit of the market, not something a careful reader can work around.

What We Do Not Know

Stated as findings, because "we do not know" is a result and should not be left for the reader to infer.

  1. No published survey of species identity in commercial bhringraj products is cited here, because none is being relied on. The proportion of retail "bhringraj" that is Eclipta versus Wedelia/Sphagneticola is, as far as this page can establish, simply unmeasured.
  2. No published survey of wedelolactone content across commercial bhringraj oils. The dose delivered by a retail taila is unknown even in principle.
  3. No comparative pharmacology of the white and yellow plants head to head on the hair endpoint. The two are used somewhat interchangeably in trade and have never been compared for the property they are bought for.
  4. The active constituent for the rodent hair effect was never identified. The extracts worked; nobody isolated the responsible molecule. So there is no compound to standardise the hair claim against, and wedelolactone is a marker of the plant rather than a marker of that activity.
  5. The identity of neela (blue) bhringaraja is unresolved in the sources available here, and this page declines to name one.

Key Research Papers

All links are PubMed searches, not numeric records. A mistyped identifier lands the reader on a different paper, often in the same journal issue, and does so invisibly. A search resolves and can be checked. Titles, journals and years are given as plain text so they can be verified independently; where this page could not verify metadata, it says so and links a topic search instead.

  1. Wagner H, Geyer B, Kiso Y, Hikino H, Rao GS. Coumestans as the main active principles of the liver drugs Eclipta alba and Wedelia calendulacea. Planta Medica, 1986. The keystone paper for this page: one study, two genera, one shared marker compound.
  2. Wagner H, Fessler B. In vitro 5-lipoxygenase inhibition by Eclipta alba extracts and the coumestan derivative wedelolactone. Planta Medica, 1986. In vitro.
  3. Roy RK, Thakur M, Dixit VK. Hair growth promoting activity of Eclipta alba in male albino rats. Archives of Dermatological Research, 2008. Animal — E. alba.
  4. Datta K, Singh AT, Mukherjee A, et al. Eclipta alba extract with potential for hair growth promoting activity. Journal of Ethnopharmacology, 2009. Animal — E. alba.
  5. Saxena AK, Singh B, Anand KK. Hepatoprotective effects of Eclipta alba on subcellular levels in rats. Journal of Ethnopharmacology, 1993. Animal — E. alba.
  6. Melo PA, Ownby CL. Ability of wedelolactone, heparin and para-bromophenacyl bromide to antagonize the myotoxic effects of two crotaline venoms. Toxicon, find on PubMed. Animal — isolated compound.
  7. Mors WB, Nascimento MC, Pereira BM, Pereira NA. Plant natural products active against snake bite — the molecular approach. Phytochemistry, 2000. Review of the Brazilian Eclipta prostrata work.
  8. Live literature search: the yellow bhringraj under all three of its binomials — a separate literature that is not evidence about Eclipta.
  9. Live literature search: DNA barcoding for herbal raw-drug authentication — the method that answers what chemistry cannot.
  10. Live literature search: wedelolactone quantification and standardisation.
  11. Live literature search: Wedelia glauca hepatotoxicity in livestock — cited only to show that genus-level reasoning is unsafe; primary metadata not asserted here.
  12. Live literature search: pyrrolizidine-alkaloid distribution within Asteraceae — the basis for clearing Eclipta of that particular family hazard.

Live PubMed Searches

  1. All three Eclipta binomials at once — the search to use.
  2. Eclipta phytochemistry
  3. Eclalbasaponins and ecliptasaponins
  4. Wedelolactone and demethylwedelolactone
  5. α-Terthienyl and thiophene phototoxicity
  6. Ecliptae Herba quality control
  7. Substitution and adulteration in Ayurvedic raw drugs
  8. Coumestans as phytoestrogens — relevant to the class, and to the caution on the safety page.

Connections

This page is educational and is not medical advice. It describes botanical nomenclature and identification; it does not assert that any particular commercial product is adulterated, and no contamination or substitution rate is claimed because none could be sourced.

Back to Table of Contents